Skip to main content

Table 2 Outcomes and laboratory indexes in patients with severe HFMD caused by EV71 in the non-CVVHDF group and the CVVHDF group

From: Continuous hemodiafiltration as a rescue therapy for patients with cardiopulmonary failure caused by enterovirus-71: a retrospective observational study in a PICU

Characteristics Non-CVVHDF group
(n = 12)
CVVHDF group
(n = 17)
P
Biochemical data
 PH 7.21 (6.94, 7.37) 7.23 (7.07, 7.31) 0.842
 PaO2/FiO2, mmHg 134 (112.5, 157.8) 135 (101.5, 160) 0.757
 Lac, mmol/L 4.35 (3.20, 5.80) 3.5 (2.8, 3.9) 0.249
 Cr, μmol/L 58.0 (28.5, 79.8) 48 (28, 77) 0.757
 ALT, IU/L 36.0 (19.8, 63.3) 35 (13, 70) 0.894
 cTnI, μg/L 0.16 (0.06, 0.38) 0.12 (0.06, 0.39) 0.877
 CK-MB, IU/L 35 (21, 73) 37 (26, 112) 0.308
Outcomes
 Duration of mechanical ventilation, day 14.5 (11.5, 20.3) 8.0 (5.5, 17.5) 0.063
 Duration of vasoactive agents, day 7.5 (6.0, 10.0) 5.0 (4.5, 7.0) 0.024
 Stay in PICU, day 23 (17, 27) 12 (9, 22) 0.030
 28-day death, n 4 3 0.403
  1. PaO2/FiO2 The ratio of the partial pressure of oxygen in arterial blood (PaO2) to the inspired oxygen fraction (FiO2), Lac Lactate, Cr Creatinine, ALT Alanine transaminase, cTnI Cardiac troponin I, CK-MB Creatine kinase-MB. Continuous variables were summarized as the median (IQR)